These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers. Scott LV, Medbak S, Dinan TG. Biol Psychiatry; 1999 Jun 01; 45(11):1447-54. PubMed ID: 10356627 [Abstract] [Full Text] [Related]
4. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V. J Clin Endocrinol Metab; 2001 Aug 01; 86(8):3545-54. PubMed ID: 11502777 [Abstract] [Full Text] [Related]
5. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome. Di Giorgio A, Hudson M, Jerjes W, Cleare AJ. Psychosom Med; 2005 Aug 01; 67(3):433-40. PubMed ID: 15911907 [Abstract] [Full Text] [Related]
6. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N. Clin Endocrinol (Oxf); 2000 May 01; 52(5):633-40. PubMed ID: 10792344 [Abstract] [Full Text] [Related]
7. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. Demitrack MA, Dale JK, Straus SE, Laue L, Listwak SJ, Kruesi MJ, Chrousos GP, Gold PW. J Clin Endocrinol Metab; 1991 Dec 01; 73(6):1224-34. PubMed ID: 1659582 [Abstract] [Full Text] [Related]
8. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Scott LV, Burnett F, Medbak S, Dinan TG. Psychol Med; 1998 Mar 01; 28(2):285-93. PubMed ID: 9572086 [Abstract] [Full Text] [Related]
12. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency. Suliman AM, Smith TP, Labib M, Fiad TM, McKenna TJ. Clin Endocrinol (Oxf); 2002 Apr 01; 56(4):533-9. PubMed ID: 11966747 [Abstract] [Full Text] [Related]
14. Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study. Scott LV, Teh J, Reznek R, Martin A, Sohaib A, Dinan TG. Psychoneuroendocrinology; 1999 Oct 01; 24(7):759-68. PubMed ID: 10451910 [Abstract] [Full Text] [Related]
16. Establishment of reference values for standard dose short synacthen test (250 microgram), low dose short synacthen test (1 microgram) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects. Gonzálbez J, Villabona C, Ramón J, Navarro MA, Giménez O, Ricart W, Soler J. Clin Endocrinol (Oxf); 2000 Aug 01; 53(2):199-204. PubMed ID: 10931101 [Abstract] [Full Text] [Related]
17. Characterization of pituitary function with emphasis on GH secretion in the chronic fatigue syndrome. Moorkens G, Berwaerts J, Wynants H, Abs R. Clin Endocrinol (Oxf); 2000 Jul 01; 53(1):99-106. PubMed ID: 10931086 [Abstract] [Full Text] [Related]